Table 1 Description of the study population between colorectal cancer patients with osteoglycin low and high expression
Variables, N (%) | OGN | P value | |
|---|---|---|---|
Low(N = 163) | High(N = 109) | ||
Gender | Â | Â | Â |
 Male | 101(62) | 62(56.9) | 0.40 |
 Female | 62(38) | 47(43.1) |  |
Age, years | 56.9 ± 10.7 | 57.3 ± 11.6 | 0.79 |
TNM stage | Â | Â | 0.43 |
 I | 14(8.6) | 7(6.4) |  |
 II | 49(30.1) | 32(29.4) |  |
 III | 73(44.8) | 58(53.2) |  |
 IV | 27(16.6) | 12(11.0) |  |
N stage | Â | Â | 0.16 |
 N0 | 74(45.4) | 46(42.2) |  |
 N1 | 53(32.5) | 28(25.7) |  |
 N2 | 36(22.1) | 35(32.1) |  |
M stage | Â | Â | 0.43 |
 M0 | 136(83.4) | 97(89.0) |  |
 M1 | 27(16.6) | 12(11.0) |  |
Grade | Â | Â | 0.55 |
 Well/ moderate | 118(72.4) | 85(78.0) |  |
 poor | 34(20.9) | 19(17.4) |  |
T stage | Â | Â | 0.74 |
 T2 | 27(16.6) | 16(14.7) |  |
 T3 | 30(18.4) | 24(22.0) |  |
 T4 | 106(65.0) | 69(63.3) |  |
Histological type | Â | Â | 0.28 |
 Adenocarcinoma | 152(93.3) | 105(96.3) |  |
 Mucinous | 11(6.7) | 4(3.7) |  |
Lymph node examined | Â | Â | 0.17 |
 Median | 15 ± 7 | 16 ± 6 |  |
Perineural invasion | Â | Â | 0.26 |
 Negative | 133(82.1) | 95(87.2) |  |
 Positive | 29(17.9) | 14(12.8) |  |
Vascular invasion | Â | Â | 0.25 |
 Negative | 108(66.3) | 75(68.8) |  |
 Positive | 51(31.3) | 34(31.2) |  |
Adjuvant Chemotherapy | Â | Â | 0.37 |
 No | 30(18.4) | 18(16.5) |  |
 Yes | 108(66.3) | 80(73.4) |  |
MS status/MMR status | Â | Â | 0.06 |
 MSS/MMR-proficient | 111(68.1) | 62(56.9) |  |
 MSI/MMR-deficient | 52(31.9) | 47(43.1) |  |